Amgen
Fighting the World's Toughest Diseases
Amgen harnesses the best of biology and technology to make people's lives easier, fuller, and longer.
"This is an extraordinary time for biotechnology. Science and technology are accelerating the cadence of innovation."Robert A. Bradway, Amgen CEO
A Biotech Leader
Amgen helped launch the biotech industry more than 40 years ago and has reached millions of patients suffering from serious illness around the globe.
Many of the molecules in our pipeline represent potential first-in-class medicines for serious diseases.
We create medicines to help patients with serious illnesses such as...
Cancer
Cardiovascular Disease
Osteoporosis
Asthma
Rheumatoid Arthritis
How We Innovate
Amgen's powerful research and development group uses cutting-edge tools like AI, generative biology and human data to discover and develop new types of medicines to fight the world's toughest diseases.
Making Medicines Safely & Reliably
Many of Amgen's medicines are made through a highly complex process involving living cells. Our motto is to deliver for "every patient, every time", and we have a long-running reputation for the reliability of our supply chain.
Operating Responsibly
Making a positive difference in the world is at the heart of what we do at Amgen — and it goes beyond making vital medicines.
We also help build a better world by focusing on environmental, social and governance (ESG) issues that matter most to our business and our stakeholders.